Literature DB >> 7370990

Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure.

S Grant, C Lehman, E Cadman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7370990

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  9 in total

Review 1.  A comparison of the effects of cytosine arabinoside and beta-lactams on DNA synthesis and cellular proliferation.

Authors:  R J Fram
Journal:  Cell Biol Toxicol       Date:  1986-12       Impact factor: 6.691

2.  Sequential oral hydroxyurea and intravenous cytosine arabinoside in refractory childhood acute leukemia: a pediatric oncology group phase 1 study.

Authors:  Ronald Dubowy; Michael Graham; Nasrollah Hakami; Morris Kletzel; Donald Mahoney; Edward Newman; Yaddanapudi Ravindranath; Bruce Camitta
Journal:  J Pediatr Hematol Oncol       Date:  2008-05       Impact factor: 1.289

3.  Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro.

Authors:  J A Streifel; S B Howell
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

4.  Significance of variation in serum thymidine concentration for the marrow toxicity of methotrexate.

Authors:  S B Howell; S J Mansfield; R Taetle
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

5.  Thymidylate synthetase-deficient mouse FM3A mammary carcinoma cell line as a tool for studying the thymidine salvage pathway and the incorporation of thymidine analogues into host cell DNA.

Authors:  J Balzarini; E De Clercq; D Ayusawa; T Seno
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

6.  A phase I-II study of combination therapy with thymidine and cytosine arabinoside.

Authors:  R Fram; P Major; E Egan; P Beardsley; D Rosenthal; D Kufe
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

Review 7.  Thymidine as an anticancer agent, alone or in combination. A biochemical appraisal.

Authors:  P H Ellims
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

8.  Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA.

Authors:  P P Major; E M Egan; G P Beardsley; M D Minden; D W Kufe
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

9.  Analysis of the drug synergism between thymidine and arabinosyl cytosine using mouse S49 T lymphoma mutants.

Authors:  A Cohen; B Ullman
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.